Patents Assigned to SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
-
Publication number: 20250064810Abstract: The present invention relates to a film coated tablet formulation comprising tofacitinib or pharmaceutically acceptable salts thereof wherein tofacitinib or pharmaceutically acceptable salts thereof has a d (0.5) particle size less than 20 ?m. Further, the present invention also relates to a simple, rapid, cost effective, time-saving and industrially convenient process.Type: ApplicationFiled: November 11, 2022Publication date: February 27, 2025Applicant: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETIInventors: Tolga GULER, Nur PEHLIVAN AKALIN, Fatih SUNEL
-
Publication number: 20210308104Abstract: The present invention relates to a pharmaceutical capsule composition comprising eltrombopag olamine or a pharmaceutically acceptable salt thereof for use in the treatment of thrombocytopenia. Furthermore, the present invention relates to an improved, simple, rapid, cost-effective, time-saving and industrially available method of preparing the capsule composition comprising eltrombopag olamine.Type: ApplicationFiled: July 26, 2019Publication date: October 7, 2021Applicant: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETIInventors: ALI TURKYILMAZ, EDIZ YILDIRIM, GULCIN TOK
-
Publication number: 20210161843Abstract: Pharmaceutical compositions comprising flurbiprofen or a pharmaceutically acceptable salt thereof in combination with at least one 5-HT1-receptor agonist or a pharmaceutically acceptable salt thereof. In this invention, the composition comprising flurbiprofen and 5-HT1-receptor agonists are used for treating or preventing migraine headache. Furthermore, in this invention, in order to overcome incompatibility and stability problems of these active agents, some solutions were offered, and stable pharmaceutical compositions have been developed.Type: ApplicationFiled: December 13, 2018Publication date: June 3, 2021Applicant: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETIInventors: Ali TURKYILMAZ, Melda MISIRLI, Emine TUNCAY, Ediz YILDIRIM
-
Patent number: 10130618Abstract: This invention is a novel pharmaceutical composition comprising dabigatran or a pharmaceutically acceptable salt thereof in combination with a proton pump inhibitor for use in the antithrombotic treatment with preventing or reducing the risk of a gastrointestinal disorder.Type: GrantFiled: April 9, 2015Date of Patent: November 20, 2018Assignee: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETIInventors: Ali Türkyilmaz, Mehtap Saydam, Yildiz Gülkok, Nur Kirat Uzunogullari, Sevgi Gökcek
-
Patent number: 9114085Abstract: Modified release oral pharmaceutical compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof in the form of a bilayer tablet and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.Type: GrantFiled: May 12, 2014Date of Patent: August 25, 2015Assignee: Sanovel Ilac Sanayi Ve Ticaret Anonim SirketiInventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
-
Patent number: 9095515Abstract: This invention is a novel pharmaceutical composition of ezetimibe or a pharmaceutically acceptable salt thereof comprising one or more pharmaceutically acceptable excipients having high bioavailability with improved solubility and dissolution rate which is stable throughout the shelflife, methods for their preparation, and methods for treatment using the same.Type: GrantFiled: March 15, 2010Date of Patent: August 4, 2015Assignee: Sanovel Ilac Sanayi Ve Ticaret Anonim SirketiInventors: Umit Cifter, Levent Oner, Ali Turkyilmaz, Ibrahim Murat Uzer, Gaye Ramazanoglu
-
Patent number: 8906949Abstract: Silicon dioxide free orally disintegrating tablet formulations of zolmitriptan or a pharmaceutically acceptable salt thereof having magnesium carbonate heavy and sodium stearyl fumarate with one or more pharmaceutically acceptable excipients and a process for preparing such a formulation and its use in the treatment of migraines.Type: GrantFiled: May 20, 2011Date of Patent: December 9, 2014Assignee: Sanovel Ilac Sanayi Ve Ticaret Anonim SirketiInventors: Umit Cifter, Ali Turkyilmaz, Gulay Yelken
-
Publication number: 20140308348Abstract: This invention is a novel pharmaceutical composition comprising flurbiprofen or a pharmaceutically acceptable salt thereof in combination with an ?-2 adrenergic receptor agonist or a gamma-aminobutiric acid receptor agonist with anti-inflammatory, analgesic and myorelaxant activity.Type: ApplicationFiled: May 20, 2014Publication date: October 16, 2014Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim SirketiInventors: Umit Cifter, Ali Turkyilmaz, Hasan Ali Turp
-
Publication number: 20140255484Abstract: Modified release oral pharmaceutical compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof in the form of a bilayer tablet and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.Type: ApplicationFiled: May 12, 2014Publication date: September 11, 2014Applicant: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETIInventors: Unit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
-
Patent number: 8778391Abstract: This invention is a novel pharmaceutical composition comprising flurbiprofen or a pharmaceutically acceptable salt thereof in combination with an ?-2 adrenergic receptor agonist or a gamma-aminobutiric acid receptor agonist with anti-inflammatory, analgesic and myorelaxant activity.Type: GrantFiled: May 8, 2008Date of Patent: July 15, 2014Assignee: Sanovel Ilac Sanayi Ve Ticaret Anonim SirketiInventors: Umit Cifter, Ali Turkyilmaz, Hasan Ali Turp
-
Patent number: 8758818Abstract: Oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof having a gradual release and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.Type: GrantFiled: September 23, 2013Date of Patent: June 24, 2014Assignee: Sanovel Ilac Sanayi ve Ticaret Anonim SirketiInventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
-
Patent number: 8753682Abstract: Dual release oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.Type: GrantFiled: September 23, 2013Date of Patent: June 17, 2014Assignee: Sanovel Ilac Sanayi ve Ticaret Anonim SirketiInventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
-
Patent number: 8741345Abstract: Modified release oral pharmaceutical compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof in the form of a bilayer tablet and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.Type: GrantFiled: May 5, 2011Date of Patent: June 3, 2014Assignee: Sanovel ILAC Sanayi Ve Ticaret Anonim SirketiInventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
-
Patent number: 8691778Abstract: A topical pharmaceutical gel includes flurbiprofen or a pharmaceutically acceptable salt of flurbiprofen, thiocolchicoside or a pharmaceutically acceptable salt of thiocolchicoside, and menthol. Pharmaceutical combinations of flurbiprofen, thiocolchicoside, and menthol in the form of topical gels with anti-inflammatory, analgesic, and myorelaxant activities are described.Type: GrantFiled: September 20, 2010Date of Patent: April 8, 2014Assignee: Sanovel Ilac Sanayi ve Ticaret Anonim SirketiInventors: Fatih Cakir, Ali Turkyilmaz, Umit Cifter
-
Publication number: 20140030328Abstract: Dual release oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.Type: ApplicationFiled: September 23, 2013Publication date: January 30, 2014Applicant: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETIInventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
-
Publication number: 20140023709Abstract: Oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof having a gradual release and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.Type: ApplicationFiled: September 23, 2013Publication date: January 23, 2014Applicant: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETIInventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
-
Patent number: 8512746Abstract: Extended release pharmaceutical compositions of levetiracetam or pharmaceutically acceptable salts thereof in the form of a tablet comprising glyceryl behenate and a polymethacrylate polymer with at least one pharmaceutically acceptable excipient.Type: GrantFiled: July 19, 2010Date of Patent: August 20, 2013Assignee: Sanovel Ilac Sanayi Ve Ticaret Anonim SirketiInventors: Hasan Ali Turp, Gulay Yelken, Asiye Sezgia, Ali Turkyilmaz, Levent Oner
-
Publication number: 20110305757Abstract: A pharmaceutical composition including a compound of Formula I (Compound I) or pharmaceutically acceptable salts thereof and one or more diuretics as effective components, wherein said one or more diuretics are selected from thiazide derivatives. Methods for preparing the pharmaceutical compound including Compound I and thiazide derivatives and its use for preventing or treating hypertension in mammals, particularly in humans.Type: ApplicationFiled: June 13, 2011Publication date: December 15, 2011Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim SirketiInventors: Umit Cifter, Ali Turkyilmaz, Onur Mutlu, Gaye Ramazanoglu
-
Publication number: 20110274753Abstract: Dual release oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.Type: ApplicationFiled: May 5, 2011Publication date: November 10, 2011Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim SirketiInventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
-
Publication number: 20110274751Abstract: A multilayered solid oral pharmaceutical formulation of trimetazidine or a pharmaceutically acceptable salt or polymorph of trimetazidine wherein one layer of said formulation provides controlled release, while the other layer provides immediate release.Type: ApplicationFiled: May 3, 2011Publication date: November 10, 2011Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim SirketiInventors: Umit Cifter, Ali Turkyilmaz, Nur Pehlivan Akalin, Aylin Yildirim, Levent Oner